Department of Psychiatry, University of Maryland School of Medicine, 630 W Fayette St, Baltimore, MD, 21201, USA.
Spring Grove Hospital and Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, Baltimore, MD, 21228, USA.
Psychiatr Q. 2018 Mar;89(1):157-168. doi: 10.1007/s11126-017-9521-z.
Popular media often portray people with a mental illness as being aggressive, violent, and incarcerated as a result of their behavior. Despite exaggeration in the media, risks for some aggressive behaviors are in fact higher in individuals with schizophrenia. This is often the case with influence of comorbid substance use disorders. It is essential that mental health professionals are aware of treatments that may help with attenuating and treating behaviors that contribute to violence, aggression and incarceration. This paper reviews violence and incarceration in individuals with schizophrenia as well as recommendations, guidelines and benefits for the use of clozapine in this population. Clozapine remains one of the most underutilized evidence-based medications available in the psychiatric arena in the United States. It is a viable and recommended option in the forensic population and it may be helpful on the path to recovery as well as bring substantial savings to the criminal justice system.
大众媒体经常将患有精神疾病的人描绘成具有攻击性、暴力和因行为而被监禁的形象。尽管媒体有夸大的成分，但事实上，精神分裂症患者确实存在更高的某些攻击性行为风险。这种情况通常与合并物质使用障碍的影响有关。心理健康专业人员必须了解可能有助于减轻和治疗导致暴力、攻击和监禁的行为的治疗方法。本文回顾了精神分裂症患者的暴力和监禁问题，以及在该人群中使用氯氮平的建议、指南和益处。氯氮平仍然是美国精神病学领域中最未被充分利用的循证药物之一。它是法医学人群中的一种可行且推荐的选择，它可能有助于康复，也可能为刑事司法系统带来大量节省。
